» Articles » PMID: 31241663

Cardiovascular Risk in Children and Adolescents with End Stage Renal Disease

Abstract

Objectives: To evaluate cardiovascular involvement in children and adolescents with End Stage Renal Disease (ESRD) and to characterize the main risk factors associated with this outcome.

Methods: Cross-sectional study of 69 children and adolescents at renal transplantation and 33 healthy individuals matched by age and gender. The study outcomes were left ventricular mass z-score (LVMZ) and carotid artery intima-media thickness (CIMT). The potential risk factors considered were age, gender, CKD etiology, use of oral vitamin D and calcium-based phosphate binders, systolic and diastolic blood pressure, body mass index z-score, time since diagnosis, dialysis duration, serum levels of ionic calcium, phosphorus, parathyroid hormone, fibroblast growth factor (FGF 23), uric acid, homocysteine, cholesterol, triglycerides, C-reactive protein (CRP), vitamin D and hemoglobin.

Results: In the multivariate analysis, the factors associated with LVMZ were dialysis duration, age, systolic blood pressure, serum hemoglobin and HDL cholesterol levels. Regarding CIMT, in the multivariate analysis, systolic blood pressure was the only factor associated with the outcome.

Conclusion: Children exhibited important cardiovascular involvement at the time of the renal transplantation. Both of the studied outcomes were independently associated with systolic blood pressure. For this reason, controlling blood pressure seems to be the main therapy to minimize cardiovascular involvement in children with ESRD.

Citing Articles

The association between systolic and diastolic dysfunction and autonomic nervous system function in children receiving chronic hemodialysis.

Elaziz O, Ahmad G, Elgawad S, Elhady F, Hamdy R Pediatr Nephrol. 2025; .

PMID: 39873803 DOI: 10.1007/s00467-024-06577-1.


Hypertension monitoring on cardiac health outcomes.

Subhash S, Satariano M, Doshi K, Bhatt G, Raina R Transl Pediatr. 2024; 13(3):518-524.

PMID: 38590375 PMC: 10998995. DOI: 10.21037/tp-23-527.


Longitudinal follow-up on vascular morphology and function in children with kidney transplants.

Bergdahl E, Westphal Ladfors S, Linner C, Brandstrom P, Hansson S, Dangardt F Acta Paediatr. 2022; 112(3):557-568.

PMID: 36567640 PMC: 10107828. DOI: 10.1111/apa.16646.


Pediatric kidney transplant and cardiometabolic risk: a cohort study.

Mosca S, Gregorio B, Costa T, Correia-Costa L, Mota C J Bras Nefrol. 2022; 44(4):511-521.

PMID: 35258072 PMC: 9838654. DOI: 10.1590/2175-8239-JBN-2021-0202.

References
1.
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice H, Okpechi I . Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015; 385(9981):1975-82. DOI: 10.1016/S0140-6736(14)61601-9. View

2.
Sinha M, Tibby S, Rasmussen P, Rawlins D, Turner C, Dalton R . Blood pressure control and left ventricular mass in children with chronic kidney disease. Clin J Am Soc Nephrol. 2010; 6(3):543-51. PMC: 3082412. DOI: 10.2215/CJN.04690510. View

3.
Balzano R, Lindblad Y, Vavilis G, Jogestrand T, Berg U, Krmar R . Use of annual ABPM, and repeated carotid scan and echocardiography to monitor cardiovascular health over nine yr in pediatric and young adult renal transplant recipients. Pediatr Transplant. 2011; 15(6):635-41. DOI: 10.1111/j.1399-3046.2011.01547.x. View

4.
Brady T, Schneider M, Flynn J, Cox C, Samuels J, Saland J . Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol. 2012; 7(12):1930-7. PMC: 3513743. DOI: 10.2215/CJN.03130312. View

5.
Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J . Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2009; 21(1):137-44. PMC: 2799282. DOI: 10.1681/ASN.2009060609. View